✦ LIBER ✦

NRF2 Is a Novel Oncogene and Biomarker of Therapeutic Resistance in Non-Small Cell Lung Cancer

✍ Scribed by Abazeed, M.; Xu, C.; Adams, D.; Tamayo, P.; Loeffler, J.; Suh, J.; Meyerson, M.; Wong, K.; Hammerman, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TAZ is a novel oncogene in non-small cel

✍ Zhou, Z; Hao, Y; Liu, N; Raptis, L; Tsao, M-S; Yang, X 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 375 KB

Oncogenes in non-small-cell lung cancer:

✍ Stella, Giulia M; Luisetti, Maurizio; Pozzi, Ernesto; Comoglio, Paolo M 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 336 KB

Chemotherapy resistance and oncogene exp

✍ Thomas A. d‘Amato; Rodney J. Landreneau; William Ricketts; Weidong Huang; Ricard 📂 Article 📅 2007 🏛 CTSNet 🌐 English ⚖ 323 KB

Osteopontin is a prognostic biomarker in

✍ Rud, Ane; Boye, Kjetil; Øijordsbakken, Miriam; Lund-Iversen, Marius; Halvorsen, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 593 KB

Dickkopf-1 autoantibody is a novel serol

✍ Yao, Xiao; Jiang, Hua; Zhang, Cuizhen; Wang, Huamao; Yang, Lin; Yu, Yongfeng; Yu 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 762 KB

Preoperative serum LMTK3 as a novel biom

✍ Xu, Zhaoguo; Qi, Xiaoying; Zhang, Xiaoye; Yu, Li 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 450 KB